Neuroprotection in Acute Ischemic Stroke

Summary

This is a pilot randomized control trial (RCT) to explore the possible beneficial effect of a novel combination therapy consisting of molecular hydrogen H2 plus minocycline ("H2M"), on neurological recovery after acute ischemic stroke.

Timeline

Start

2017-08-02

Primary completion

2019-08-13

Completion

2019-08-13

Drugs

Indications